Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal

Year.

As previously announced, effective on February 23, 2021, TransEnterix, Inc. (the "Company") changed its name to Asensus Surgical, Inc.

On March 5, 2021, the trading symbol of the Company's common stock on the NYSE American will be changed to "ASXC."

The Company's CUSIP numbers for its common stock, Series C Warrants and Series D Warrants have changed as a result of the corporate name change. Effective on March 5, 2021, the new CUSIP numbers for the Company's common stock, Series C Warrants and Series D Warrants are 04367G 103, 04367G 111 and 04367G 129, respectively.

A copy of the Company's Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware to effectuate the name change, is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference. A copy of the Company's Amended and Restated Bylaws reflecting the corporate name change is filed as Exhibit 3.2 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits





(d) Exhibits



Exhibit No. Description

3.1 Amended and Restated Certificate of Incorporation of Asensus Surgical,

Inc., filed and effective February 23, 2021





3.2   Amended and Restated Bylaws of Asensus Surgical, Inc.

104 Cover Page Interactive Data File (formatted in inline XBRL)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses